NCT00238992View on ClinicalTrials.gov

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.

PHASE3CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

July 31, 2005

Conditions
Kidney de Novo Transplant
Interventions
DRUG

Enteric-coated Mycophenolate sodium (EC-MPS)

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY